[go: up one dir, main page]

ES2134237T3 - Composiciones farmaceuticas que contienen acido ursodesoxicolico. - Google Patents

Composiciones farmaceuticas que contienen acido ursodesoxicolico.

Info

Publication number
ES2134237T3
ES2134237T3 ES93118886T ES93118886T ES2134237T3 ES 2134237 T3 ES2134237 T3 ES 2134237T3 ES 93118886 T ES93118886 T ES 93118886T ES 93118886 T ES93118886 T ES 93118886T ES 2134237 T3 ES2134237 T3 ES 2134237T3
Authority
ES
Spain
Prior art keywords
acid
ursodesoxicolico
pharmaceutical compositions
compositions containing
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93118886T
Other languages
English (en)
Inventor
Aldo Olivieri
Claudio Camponeschi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOPROGRESS SpA
Original Assignee
BIOPROGRESS SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOPROGRESS SpA filed Critical BIOPROGRESS SpA
Application granted granted Critical
Publication of ES2134237T3 publication Critical patent/ES2134237T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION QUE CONTIENEN ACIDO URSODEOXICLOLICO COMO INGREDIENTE ACTIVO EN FORMA DE MICROGRANULO OBTENIDOS POR EXTRUSION-ESFERONIZACION DE UNA MEZCLA DE DICHO ACIDO Y EXCIPIENTES COMUNES. SE OBTIENE LA REPOSICION CONTROLADA DE DICHO INGREDIENTE ACTIVO.
ES93118886T 1992-11-27 1993-11-24 Composiciones farmaceuticas que contienen acido ursodesoxicolico. Expired - Lifetime ES2134237T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922721A IT1255968B (it) 1992-11-27 1992-11-27 Composizioni farmaceutiche contenenti acido ursodesossicolico

Publications (1)

Publication Number Publication Date
ES2134237T3 true ES2134237T3 (es) 1999-10-01

Family

ID=11364369

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93118886T Expired - Lifetime ES2134237T3 (es) 1992-11-27 1993-11-24 Composiciones farmaceuticas que contienen acido ursodesoxicolico.

Country Status (5)

Country Link
EP (1) EP0599282B1 (es)
AT (1) ATE180969T1 (es)
DE (1) DE69325236T2 (es)
ES (1) ES2134237T3 (es)
IT (1) IT1255968B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772220B2 (en) 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
ITMI20012572A1 (it) * 2001-12-06 2003-06-06 Istituto Biochimico Italiano Microgranuli di acido ursodesossicolico
US7145125B2 (en) 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
CA2577268A1 (en) 2004-08-30 2006-03-09 Seo Hong Yoo Neuroprotective effect of solubilized udca in focal ischemic model
DE602005027727D1 (de) 2004-10-15 2011-06-09 Seo Hong Yoo Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
AU2004325203A1 (en) * 2004-11-24 2006-06-01 Seo Hong Yoo Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
AU2008241690A1 (en) * 2007-04-19 2008-10-30 Disphar International B.V. High dose composition of ursodeoxycholic acid
MX2009001925A (es) * 2009-02-20 2010-08-20 Senosiain S A De C V Lab Composicion farmaceutica oral para uso en enfermedades respiratorias.
ITTO20111064A1 (it) * 2011-11-18 2013-05-19 Abc Farmaceutici S P A Compresse a rilascio protratto, comprendenti acido ursodesossicolico
US20220304937A1 (en) * 2015-09-16 2022-09-29 Laboratoires C.T.R.S. Pediatric formulation
CN107095858B (zh) * 2017-06-27 2020-04-10 石家庄学院 一种熊去氧胆酸胶囊及其制备方法
CN107496928B (zh) * 2017-09-11 2020-07-14 石家庄学院 一种熊去氧胆酸干混悬剂及其制备方法
WO2020260413A1 (fr) * 2019-06-28 2020-12-30 Tilman Sa Composition comprenant au moins un triterpène et/ou au moins un triterpénoïde et/ou au moins une de leurs formes glycosylées
CN110478304B (zh) * 2019-08-20 2022-07-05 广州市金熊大健康科技有限公司 一种含有熊胆微胶囊的牙膏
AU2023313512A1 (en) * 2022-07-25 2025-01-30 Shilpa Medicare Limited Pharmaceutical compositions of nor-udca

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0747539B2 (ja) * 1986-10-22 1995-05-24 東京田辺製薬株式会社 胆汁酸固形製剤
GB8722306D0 (en) * 1987-09-22 1987-10-28 Aps Research Ltd Sustained-release formulation
IT1245891B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.
US5260074A (en) * 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof

Also Published As

Publication number Publication date
ATE180969T1 (de) 1999-06-15
ITMI922721A1 (it) 1994-05-27
IT1255968B (it) 1995-11-17
DE69325236D1 (de) 1999-07-15
DE69325236T2 (de) 2000-01-27
EP0599282A1 (en) 1994-06-01
EP0599282B1 (en) 1999-06-09
ITMI922721A0 (it) 1992-11-27

Similar Documents

Publication Publication Date Title
ES2134237T3 (es) Composiciones farmaceuticas que contienen acido ursodesoxicolico.
ATE61050T1 (de) Pyridazinamine wirksam gegen viren.
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
AU6542986A (en) Pyridyl-methylthio substituted benzimidazoles
BR9107124A (pt) Novos derivados de acido hidroxamico e de n-hidroxiureia e seu uso
ES2063146T3 (es) Composiciones farmaceuticas que contienen acido n-(3,4-dimetoxicinamoil)-antranilico.
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
DK0443224T3 (da) Anvendelse af thrombospondin til fremskyndelse af sårheling
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
FI955403A0 (fi) Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä
ITMI930582A1 (it) Composizione farmeceutiche ad attivita' analgesica
ES2090083T3 (es) Derivados de cefalosporina, procedimiento para su preparacion y composicion antimicrobiana que contiene estos derivados.
DK0693926T3 (da) Ny farmaceutisk sammensætning til fremstilling af et stabilt pulver indeholdende en kombination af acetylsalicylsyre og metoclopramid som aktiv bestanddel.
PH27446A (en) Compound with gastric acid inhibitory effect
RU95113437A (ru) (h±)-сложный этиловый эфир транс-2-диметиламино-1-фенил-3-циклогексентранс-1-карбоновой кислоты в виде первичного ортофосфата и твердая фармацевтическая композиция с обезболивающей активностью
SE8600658D0 (sv) Novel composition of matter
DE69314463D1 (de) Hautregenerierende kosmetische zusammensetzung
AR010432A1 (es) Composiciones farmaceuticas que contienen acido ricinoleico y su uso para la terapia antiinflamatoria y analgesica
ES2076201T3 (es) Derivados de 3-piperidinil-indazol antihipertensivos.
IT1140789B (it) Esteri sostituiti dell'acido ciclopropancarbossilico e composizioni insetticide che contengono i medesimi come ingrediente attivo
ES2087178T3 (es) Disulfato de ws7622a, procedimiento para su preparacion y su uso.
ES535408A0 (es) Un metodo de producir una composicion farmaceutica que contiene isoxicamato de l-arginina como ingrediente activo.
IT1216103B (it) Peptidi ad attivita' farmaceutica.
MX9705592A (es) Composiciones farmaceuticas que contienen corticosteroides y preparacion de las mismas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 599282

Country of ref document: ES